VenatoRx Pharmaceuticals’ Christopher J. Burns, Ph.D. Named CEO of the Year by Life Sciences Pennsylvania

40

MALVERN, Pa.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/antibiotics?src=hash" target="_blank"gt;#antibioticslt;/agt;–Christopher J. Burns, Ph.D., President and CEO of VenatoRx Pharmaceuticals was named the 2018 "Frank Baldino CEO of the Year” by LSPA. http://www.businesswire.com/news/home/20190314005462/en/VenatoRx-Pharmaceuticals%E2%80%99-Christopher-J.-Burns-Ph.D.-Named/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==